Report

Our reports provide latest industry trends, forecasts, company profiles, competitive landscape, and strategic insights.

Asset 41 2
160 1608792 circle document icon png transparent png

Infectious Disease Diagnostics Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Product (Kits & Reagents, Instruments, and Software & Services), Technology  (Biosensor-Based, Immunodiagnostics, Molecular-Based Diagnostic Techniques, Clinical Biology, and Others), Application Type (Laboratory Testing and Point-of-Care Testing), Testing Type (Human Testing and Veterinary Testing), End User (Diagnostic Laboratories, Hospitals & Clinics, Research Institutes, Homecare Settings, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)

The infectious disease diagnostics market is expected to grow from US$ 38.366 billion in 2022 to US$ 59.954 billion by 2030; it is anticipated to register a CAGR of 5.7% from 2022 to 2030. The growing incidence of infectious diseases across the world and rising application of diagnostics in veterinary infectious diseases bolster the infectious disease diagnostics market size. However, an inadequate reimbursement scenario hinders the infectious disease diagnostics market growth.

Rising Incidence of Infectious Diseases Drive Infectious Disease Diagnostics Market Growth

Fungi, viruses, parasites, bacteria, and toxic products are among the infectious agents that can cause infectious diseases. Public health is adversely affected by infectious diseases, causing morbidity, mortality, and economic burdens. Rising incidence of infectious diseases propels the requirement for accurate and timely diagnosis to form the basis for effective disease management, treatment, and prevention. Diagnosing and monitoring multiple infections and diseases, including hepatitis C, HIV, tuberculosis, human papillomavirus, and sexually transmitted infections (STIs), and infectious disease outbreaks can be performed using molecular diagnostics techniques, laboratory-based assays, and point-of-care tests. According to the Centers for Disease Control and Prevention (CDC), ~10.2 million people visited physician offices for the treatment of infectious and parasitic diseases in African countries every year. According to an article published in the National Library of Medicine (NLM) in 2021, infectious diseases are a major concern in most African countries due to high disease burden and limited healthcare resources. More than 200 pathogens can cause fever in Nigeria, one of the most common reasons for visiting a healthcare facility. According to the World Health Organization (WHO), ~58 million people across the world suffer from chronic hepatitis C infection, and ~1.5 million new infections are diagnosed every year. HIV is a major public health issue across the world. According to The Joint United Nations Programme on HIV/AIDS (UNAIDS), in 2020, ~ 37.7 million people had HIV. Out of these, ~36 million people were adults, and about 1.7 million were children aged 0–14 years. Also, ~1.5 million new HIV cases were reported globally in 2020.

According to WHO, tuberculosis (TB) is the 13th leading cause of death across the world, and it is the second leading infectious disease that leads to death after COVID-19. According to the WHO, 1.5 million deaths were caused by TB in 2020. In 2020, WHO projected that 10 million people had TB across the world, Furthermore, in 2020, 30 countries with high TB burdens accounted for 86% of new TB cases. Eight countries make up two-thirds of the total cases of TB, with India at the forefront, followed by China, the Philippines, Indonesia, Nigeria, Pakistan, Bangladesh, and South Africa. Thus, the upsurging incidence of infectious diseases bolsters the need for infectious disease diagnostic technologies, such as microbial culture, hemagglutination inhibition tests, and enzyme-linked immunosorbent assays (ELISA).

The report segments the infectious disease diagnostics market as follows:

The infectious disease diagnostics market, by product, is segmented into kits & reagents, instruments, and software & services. The infectious disease diagnostics market, by technology, is segmented into biosensor-based, immunodiagnostics, molecular-based diagnostic, clinical biology, and others. The market for the immunodiagnostics segment is further segmented into enzyme-linked immunosorbent assay, western blotting analysis, and immunofluorescence assay. The market for the molecular-based diagnostic techniques segment is further segmented into polymerase chain reaction, in situ hybridization, isothermal nucleic acid amplification technology, next generation sequencing, DNA microarrays, and others. The infectious disease diagnostics market, by application type, is bifurcated into point-of-care testing and laboratory testing. The infectious disease diagnostics market, by testing type, is bifurcated into human testing and veterinary testing. The market for the human testing segment is further segmented into HIV, Hepatitis, HAIs, HPV, tuberculosis, influenza, and others. The infectious disease diagnostics market, by end user, is segmented into diagnostic laboratories, hospitals and clinics, research institutes, homecare settings, and others. Based on geography, the infectious disease diagnostics market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Product-Based Insights

The infectious disease diagnostics market, by product, is segmented into kits & reagents, instruments, and software & services. In 2022, the kits & reagents segment held the largest share of the market. However, the market for the software & services segment is expected to grow at the fastest rate during 2022–2030.

Regional-Based Insights

Based on geography, the infectious disease diagnostics market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is the largest contributor to the growth of the global infectious disease diagnostics market. Asia Pacific is expected to register the highest CAGR in the infectious disease diagnostics market during 2022–2030. The infectious diseases diagnostics market growth in the US is primarily driven by the increasing prevalence of infectious diseases, rising geriatric population, and growing number of product launches by key players.

Abbott Laboratories, Bruker Corp, Cardinal Health, F. Hoffmann-La Roche Ltd, Trinity Biotech Plc, Danaher Corp, Bio-Rad Laboratories Inc, AccuBioTech Co Ltd, ACON Laboratories, and DiaSorin SpA are among the prominent players operating in the infectious disease diagnostics market. These companies focus on new product launches and geographic expansions to meet the growing consumer demand across the world and increase their product range in specialty portfolios. Their global presence allows them to serve a large base of customers, subsequently facilitating market expansion.

A few of the major primary and secondary sources referred to while preparing the report on the infectious disease diagnostics market are the World Health Organization (WHO), the US Census Bureau, The Journal for Infectious Diseases, International Journal of Infectious Diseases, and CDC, among others.

TABLE OF CONTENTS

1. Introduction 39
1.1 The Insight Partners Research Report Guidance. 39
1.2 Market Segmentation. 40
2. Executive Summary 42
2.1 Key Insights. 42
2.2 Infectious Disease Diagnostics Market, by Geography (US$ Million) 43
3. Research Methodology 44
3.1 Coverage. 45
3.2 Secondary Research. 45
3.3 Primary Research. 45
4. Infectious Disease Diagnostics Market Landscape 47
4.1 Overview. 47
4.2 PEST Analysis. 47
4.2.1 Global PEST Analysis. 47
5. Infectious Disease Diagnostics Market – Key Industry Dynamics 48
5.1 Market Drivers: 48
5.1.1 Rising Incidence of Infectious Diseases. 48
5.1.2 Rising Application of Diagnostics in Veterinary Infectious Disease. 50
5.2 Market Restraints. 50
5.2.1 Inadequate Reimbursement Scenario. 50
5.3 Market Opportunities. 51
5.3.1 Increasing Focus on R&D and Funding in Infectious Disease Diagnostics. 51
5.4 Future Trends. 52
5.4.1 Rising Number of Product Approvals and Launches. 52
5.5 Impact Analysis: 52
6. Infectious Disease Diagnostics Market – Global Market Analysis 54
6.1 Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 – 2030. 54
7. Global Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by Product 56
7.1 Overview. 56
7.2 Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%) 56
7.3 Kits & Reagents. 57
7.3.1 Overview. 57
7.3.2 Kits & Reagents: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 57
7.4 Instruments. 58
7.4.1 Overview. 58
7.4.2 Instruments: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 58
7.5 Software & Services. 59
7.5.1 Overview. 59
7.5.2 Software & Services: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 59
8. Global Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by Technology 60
8.1 Overview. 60
8.2 Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%) 60
8.3 Biosensor-based. 61
8.3.1 Overview. 61
8.3.2 Biosensor-based: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 61
8.4 Immunodiagnostics. 62
8.4.1 Overview. 62
8.4.2 Immunodiagnostics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 62
8.4.2.1 Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 63
8.5 Molecular-Based Diagnostic Techniques. 64
8.5.1 Overview. 64
8.5.2 Molecular-Based Diagnostic Techniques: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 64
8.5.2.1 Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 64
8.6 Clinical Biology. 66
8.6.1 Overview. 66
8.6.2 Clinical Biology: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 66
8.7 Others. 67
8.7.1 Overview. 67
8.7.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 67
9. Global Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by Application Type 68
9.1 Overview. 68
9.2 Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%) 68
9.3 Point-of-Care Testing. 69
9.3.1 Overview. 69
9.3.2 Point-of-Care Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 69
9.4 Laboratory Testing. 70
9.4.1 Overview. 70
9.4.2 Laboratory Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 70
10. Global Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by Testing Type 71
10.1 Overview. 71
10.2 Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%) 71
10.3 Human Testing. 72
10.3.1 Overview. 72
10.3.2 Human Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 72
10.3.2.1 Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 73
10.4 Veterinary Testing. 74
10.4.1 Overview. 74
10.4.2 Veterinary Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 74
11. Global Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by End User 75
11.1 Overview. 75
11.2 Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%) 75
11.3 Diagnostic Laboratories. 76
11.3.1 Overview. 76
11.3.2 Diagnostic Laboratories: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 76
11.4 Hospitals and Clinics. 77
11.4.1 Overview. 77
11.4.2 Hospitals and Clinics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 77
11.5 Research Institutes. 78
11.5.1 Overview. 78
11.5.2 Research Institutes: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 78
11.6 Homecare Settings. 80
11.6.1 Overview. 80
11.6.2 Homecare Settings: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 80
11.7 Others. 81
11.7.1 Overview. 81
11.7.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 81
12. Infectious Disease Diagnostics Market – Geographical Analysis 82
12.1 North America Infectious Disease Diagnostics Market, Revenue and Forecast To 2030. 82
12.1.1 Overview. 82
12.1.2 North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 83
12.1.3 North America: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 83
12.1.4 North America: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 84
12.1.4.1 North America: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 84
12.1.4.2 North America: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 85
12.1.5 North America: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 85
12.1.6 North America: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 86
12.1.6.1 North America: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 86
12.1.7 North America: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 87
12.1.8 North America Infectious Disease Diagnostics Market, by Country. 87
12.1.8.1 US. 88
12.1.8.1.1 Overview.. 88
12.1.8.1.2 US Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 88
12.1.8.1.3 US: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 88
12.1.8.1.4 US: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 90
12.1.8.1.4.1 US: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 90
12.1.8.1.4.2 US: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 91
12.1.8.1.5 US: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 92
12.1.8.1.6 US: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 92
12.1.8.1.6.1 US: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 92
12.1.8.1.7 US: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 93
12.1.8.2 Canada. 94
12.1.8.2.1 Overview.. 94
12.1.8.2.2 Canada Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 94
12.1.8.2.3 Canada: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 95
12.1.8.2.4 Canada: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 96
12.1.8.2.4.1 Canada: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 96
12.1.8.2.4.2 Canada: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 97
12.1.8.2.5 Canada: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 97
12.1.8.2.6 Canada: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 98
12.1.8.2.6.1 Canada: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 98
12.1.8.2.7 Canada: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 99
12.1.8.3 Mexico. 100
12.1.8.3.1 Overview.. 100
12.1.8.3.2 Mexico Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 100
12.1.8.3.3 Mexico: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 101
12.1.8.3.4 Mexico: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 102
12.1.8.3.4.1 Mexico: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 102
12.1.8.3.4.2 Mexico: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 103
12.1.8.3.5 Mexico: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 103
12.1.8.3.6 Mexico: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 103
12.1.8.3.6.1 Mexico: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 104
12.1.8.3.7 Mexico: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 104
12.2 Europe Infectious Disease Diagnostics Market, Revenue and Forecast to 2030. 105
12.2.1 Overview. 105
12.2.2 Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 106
12.2.3 Europe: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 106
12.2.4 Europe: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 107
12.2.4.1 Europe: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 107
12.2.4.2 Europe: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 108
12.2.5 Europe: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 108
12.2.6 Europe: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 109
12.2.6.1 Europe: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 109
12.2.7 Europe: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 110
12.2.8 Europe Infectious Disease Diagnostics Market, by Country. 110
12.2.8.1 UK.. 111
12.2.8.1.1 Overview.. 111
12.2.8.1.2 UK Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 111
12.2.8.1.3 UK: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 111
12.2.8.1.4 UK: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 113
12.2.8.1.4.1 UK: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 113
12.2.8.1.4.2 UK: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 114
12.2.8.1.5 UK: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 114
12.2.8.1.6 UK: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 115
12.2.8.1.6.1 UK: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 115
12.2.8.1.7 UK: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 116
12.2.8.2 Germany. 117
12.2.8.2.1 Overview.. 117
12.2.8.2.2 Germany Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 117
12.2.8.2.3 Germany: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 118
12.2.8.2.4 Germany: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 119
12.2.8.2.4.1 Germany: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 119
12.2.8.2.4.2 Germany: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 120
12.2.8.2.5 Germany: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 120
12.2.8.2.6 Germany: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 121
12.2.8.2.6.1 Germany: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 121
12.2.8.2.7 Germany: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 122
12.2.8.3 France. 123
12.2.8.3.1 Overview.. 123
12.2.8.3.2 France Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 123
12.2.8.3.3 France: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 123
12.2.8.3.4 France: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 125
12.2.8.3.4.1 France: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 125
12.2.8.3.4.2 France: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 126
12.2.8.3.5 France: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 126
12.2.8.3.6 France: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 127
12.2.8.3.6.1 France: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 127
12.2.8.3.7 France: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 128
12.2.8.4 Italy. 129
12.2.8.4.1 Overview.. 129
12.2.8.4.2 Italy Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 129
12.2.8.4.3 Italy: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 129
12.2.8.4.4 Italy: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 131
12.2.8.4.4.1 Italy: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 131
12.2.8.4.4.2 Italy: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 132
12.2.8.4.5 Italy: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 132
12.2.8.4.6 Italy: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 132
12.2.8.4.6.1 Italy: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 133
12.2.8.4.7 Italy: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 133
12.2.8.5 Spain. 134
12.2.8.5.1 Overview.. 134
12.2.8.5.2 Spain Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 134
12.2.8.5.3 Spain: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 134
12.2.8.5.4 Spain: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 136
12.2.8.5.4.1 Spain: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 136
12.2.8.5.4.2 Spain: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 137
12.2.8.5.5 Spain: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 137
12.2.8.5.6 Spain: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 137
12.2.8.5.6.1 Spain: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 138
12.2.8.5.7 Spain: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 138
12.2.8.6 Rest of Europe. 139
12.2.8.6.1 Overview.. 139
12.2.8.6.2 Rest of Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 139
12.2.8.6.3 Rest of Europe: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 139
12.2.8.6.4 Rest of Europe: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 141
12.2.8.6.4.1 Rest of Europe: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 141
12.2.8.6.4.2 Rest of Europe: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 142
12.2.8.6.5 Rest of Europe: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 142
12.2.8.6.6 Rest of Europe: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 143
12.2.8.6.6.1 Rest of Europe: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 143
12.2.8.6.7 Rest of Europe: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 144
12.3 Asia Pacific Infectious Disease Diagnostics Market, Revenue and Forecast to 2030. 145
12.3.1 Overview. 145
12.3.2 Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 146
12.3.3 Asia Pacific: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 146
12.3.4 Asia Pacific: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 147
12.3.4.1 Asia Pacific: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 147
12.3.4.2 Asia Pacific: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 148
12.3.5 Asia Pacific: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 148
12.3.6 Asia Pacific: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 149
12.3.6.1 Asia Pacific: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 149
12.3.7 Asia Pacific: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 150
12.3.8 Asia Pacific Infectious Disease Diagnostics Market, by Country. 151
12.3.8.1 China. 151
12.3.8.1.1 Overview.. 151
12.3.8.1.2 China Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 151
12.3.8.1.3 China: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 153
12.3.8.1.4 China: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 153
12.3.8.1.4.1 China: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 154
12.3.8.1.4.2 China: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 154
12.3.8.1.5 China: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 155
12.3.8.1.6 China: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 155
12.3.8.1.6.1 China: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 156
12.3.8.1.7 China: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 156
12.3.8.2 Japan. 157
12.3.8.2.1 Overview.. 157
12.3.8.2.2 Japan Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 157
12.3.8.2.3 Japan: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 157
12.3.8.2.4 Japan: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 159
12.3.8.2.4.1 Japan: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 159
12.3.8.2.4.2 Japan: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 160
12.3.8.2.5 Japan: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 160
12.3.8.2.6 Japan: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 160
12.3.8.2.6.1 Japan: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 161
12.3.8.2.7 Japan: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 161
12.3.8.3 India. 162
12.3.8.3.1 Overview.. 162
12.3.8.3.2 India Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 162
12.3.8.3.3 India: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 162
12.3.8.3.4 India: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 164
12.3.8.3.4.1 India: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 164
12.3.8.3.4.2 India: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 165
12.3.8.3.5 India: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 165
12.3.8.3.6 India: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 165
12.3.8.3.6.1 India: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 166
12.3.8.3.7 India: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 166
12.3.8.4 South Korea. 167
12.3.8.4.1 Overview.. 167
12.3.8.4.2 South Korea Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 167
12.3.8.4.3 South Korea: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 167
12.3.8.4.4 South Korea: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 169
12.3.8.4.4.1 South Korea: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 169
12.3.8.4.4.2 South Korea: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 170
12.3.8.4.5 South Korea: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 170
12.3.8.4.6 South Korea: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 170
12.3.8.4.6.1 South Korea: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 171
12.3.8.4.7 South Korea: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 171
12.3.8.5 Australia. 172
12.3.8.5.1 Overview.. 172
12.3.8.5.2 Australia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 172
12.3.8.5.3 Australia: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 172
12.3.8.5.4 Australia: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 174
12.3.8.5.4.1 Australia: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 174
12.3.8.5.4.2 Australia: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 175
12.3.8.5.5 Australia: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 175
12.3.8.5.6 Australia: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 175
12.3.8.5.6.1 Australia: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 176
12.3.8.5.7 Australia: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 176
12.3.8.6 Rest of Asia Pacific. 177
12.3.8.6.1 Overview.. 177
12.3.8.6.2 Rest of Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 177
12.3.8.6.3 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 177
12.3.8.6.4 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 179
12.3.8.6.4.1 Rest of Asia Pacific: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 179
12.3.8.6.4.2 Rest of Asia Pacific: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 180
12.3.8.6.5 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 180
12.3.8.6.6 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 181
12.3.8.6.6.1 Rest of Asia Pacific: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 181
12.3.8.6.7 Rest of Asia Pacific: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 182
12.4 Middle East & Africa Infectious Disease Diagnostics Market, Revenue and Forecast to 2030. 183
12.4.1 Overview. 183
12.4.2 Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 184
12.4.3 Middle East & Africa: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 184
12.4.4 Middle East & Africa: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 185
12.4.4.1 Middle East & Africa: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 185
12.4.4.2 Middle East & Africa: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 186
12.4.5 Middle East & Africa: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 186
12.4.6 Middle East & Africa: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 187
12.4.6.1 Middle East & Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 187
12.4.7 Middle East & Africa: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 188
12.4.7.1 Middle East & Africa Infectious Disease Diagnostics Market, by Country. 188
12.4.7.2 Saudi Arabia. 189
12.4.7.2.1 Overview.. 189
12.4.7.2.2 Saudi Arabia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 189
12.4.7.2.3 Saudi Arabia: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 189
12.4.7.2.4 Saudi Arabia: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 191
12.4.7.2.4.1 Saudi Arabia: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 191
12.4.7.2.4.2 Saudi Arabia: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 192
12.4.7.2.5 Saudi Arabia: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 192
12.4.7.2.6 Saudi Arabia: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 192
12.4.7.2.6.1 Saudi Arabia: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 193
12.4.7.2.7 Saudi Arabia: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 193
12.4.7.3 South Africa. 194
12.4.7.3.1 Overview.. 194
12.4.7.3.2 South Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 194
12.4.7.3.3 South Africa: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 194
12.4.7.3.4 South Africa: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 196
12.4.7.3.4.1 South Africa: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 196
12.4.7.3.4.2 South Africa: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 197
12.4.7.3.5 South Africa: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 197
12.4.7.3.6 South Africa: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 197
12.4.7.3.6.1 South Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 198
12.4.7.3.7 South Africa: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 198
12.4.7.4 UAE. 199
12.4.7.4.1 Overview.. 199
12.4.7.4.2 UAE Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 199
12.4.7.4.3 UAE: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 199
12.4.7.4.4 UAE: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 201
12.4.7.4.4.1 UAE: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 201
12.4.7.4.4.2 UAE: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 202
12.4.7.4.5 UAE: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 202
12.4.7.4.6 UAE: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 202
12.4.7.4.6.1 UAE: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 203
12.4.7.4.7 UAE: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 203
12.4.7.5 Rest of Middle East & Africa. 204
12.4.7.5.1 Overview.. 204
12.4.7.5.2 Rest of Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 204
12.4.7.5.3 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 204
12.4.7.5.4 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 206
12.4.7.5.4.1 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 206
12.4.7.5.4.2 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 207
12.4.7.5.5 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 207
12.4.7.5.6 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 208
12.4.7.5.6.1 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 208
12.4.7.5.7 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 209
12.5 South & Central America Infectious Disease Diagnostics Market, Revenue and Forecast to 2030. 210
12.5.1 Overview. 210
12.5.2 South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 211
12.5.3 South & Central America: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 211
12.5.4 South & Central America: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 212
12.5.4.1 South & Central America: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 212
12.5.4.2 South & Central America: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 213
12.5.5 South & Central America: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 213
12.5.6 South & Central America: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 214
12.5.6.1 South & Central America: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 214
12.5.7 South & Central America: Infectious Disease Diagnostics Market, by End User, 2020–2030 (US$ Million) 215
12.5.8 South & Central America Infectious Disease Diagnostics Market, by Country. 215
12.5.8.1 Brazil 216
12.5.8.1.1 Overview.. 216
12.5.8.1.2 Brazil Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 216
12.5.8.1.3 Brazil: Infectious Disease Diagnostics Market, by Product, 2020–2030 (US$ Million) 216
12.5.8.1.4 Brazil: Infectious Disease Diagnostics Market, by Technology, 2020–2030 (US$ Million) 218
12.5.8.1.4.1 Brazil: Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020–2030 (US$ Million) 218
12.5.8.1.4.2 Brazil: Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020–2030 (US$ Million) 219
12.5.8.1.5 Brazil: Infectious Disease Diagnostics Market, by Application Type, 2020–2030 (US$ Million) 219
12.5.8.1.6 Brazil: Infectious Disease Diagnostics Market, by Testing Type, 2020–2030 (US$ Million) 219
12.5.8.1.6.1 Brazil: Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020–2030 (US$ Million) 220
12.5.8.1.7 Brazil: Infectious Disease Diagnostics Market, by End Use

LIST OF TABLES

Table 1. Infectious Disease Diagnostics Market Segmentation. 40
Table 2. Infectious Diseases and Fundings. 51
Table 3. Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 63
Table 4. Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 64
Table 5. Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 73
Table 6. North America Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 83
Table 7. North America Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 84
Table 8. North America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 84
Table 9. North America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 85
Table 10. North America Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 85
Table 11. North America Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 86
Table 12. North America Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 86
Table 13. North America Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 87
Table 14. US Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 88
Table 15. US Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 90
Table 16. US Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 90
Table 17. US Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 91
Table 18. US Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 92
Table 19. US Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 92
Table 20. US Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 92
Table 21. US Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 93
Table 22. Canada Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 95
Table 23. Canada Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 96
Table 24. Canada Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 96
Table 25. Canada Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 97
Table 26. Canada Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 97
Table 27. Canada Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 98
Table 28. Canada Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 98
Table 29. Canada Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 99
Table 30. Mexico Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 101
Table 31. Mexico Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 102
Table 32. Mexico Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 102
Table 33. Mexico Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 103
Table 34. Mexico Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 103
Table 35. Mexico Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 103
Table 36. Mexico Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 104
Table 37. Mexico Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 104
Table 38. Europe Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 106
Table 39. Europe Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 107
Table 40. Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 107
Table 41. Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 108
Table 42. Europe Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 108
Table 43. Europe Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 109
Table 44. Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 109
Table 45. Europe Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 110
Table 46. UK Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 111
Table 47. UK Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 113
Table 48. UK Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 113
Table 49. UK Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 114
Table 50. UK Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 114
Table 51. UK Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 115
Table 52. UK Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 115
Table 53. UK Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 116
Table 54. Germany Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 118
Table 55. Germany Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 119
Table 56. Germany Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 119
Table 57. Germany Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 120
Table 58. Germany Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 120
Table 59. Germany Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 121
Table 60. Germany Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 121
Table 61. Germany Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 122
Table 62. France Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 123
Table 63. France Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 125
Table 64. France Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 125
Table 65. France Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 126
Table 66. France Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 126
Table 67. France Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 127
Table 68. France Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 127
Table 69. France Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 128
Table 70. Italy Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 129
Table 71. Italy Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 131
Table 72. Italy Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 131
Table 73. Italy Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 132
Table 74. Italy Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 132
Table 75. Italy Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 132
Table 76. Italy Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 133
Table 77. Italy Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 133
Table 78. Spain Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 134
Table 79. Spain Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 136
Table 80. Spain Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 136
Table 81. Spain Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 137
Table 82. Spain Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 137
Table 83. Spain Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 137
Table 84. Spain Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 138
Table 85. Spain Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 138
Table 86. Rest of Europe Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 140
Table 87. Rest of Europe Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 141
Table 88. Rest of Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 141
Table 89. Rest of Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 142
Table 90. Rest of Europe Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 142
Table 91. Rest of Europe Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 143
Table 92. Rest of Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 143
Table 93. Rest of Europe Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 144
Table 94. Asia Pacific Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 146
Table 95. Asia Pacific Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 147
Table 96. Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 147
Table 97. Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 148
Table 98. Asia Pacific Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 148
Table 99. Asia Pacific Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 149
Table 100. Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 149
Table 101. Asia Pacific Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 150
Table 102. China Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 153
Table 103. China Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 153
Table 104. China Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 154
Table 105. China Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 154
Table 106. China Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 155
Table 107. China Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 155
Table 108. China Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 156
Table 109. China Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 156
Table 110. Japan Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 157
Table 111. Japan Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 159
Table 112. Japan Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 159
Table 113. Japan Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 160
Table 114. Japan Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 160
Table 115. Japan Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 160
Table 116. Japan Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 161
Table 117. Japan Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 161
Table 118. India Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 162
Table 119. India Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 164
Table 120. India Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 164
Table 121. India Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 165
Table 122. India Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 165
Table 123. India Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 165
Table 124. India Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 166
Table 125. India Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 166
Table 126. South Korea Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 167
Table 127. South Korea Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 169
Table 128. South Korea Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 169
Table 129. South Korea Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 170
Table 130. South Korea Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 170
Table 131. South Korea Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 170
Table 132. South Korea Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 171
Table 133. South Korea Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 171
Table 134. Australia Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 172
Table 135. Australia Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 174
Table 136. Australia Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 174
Table 137. Australia Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 175
Table 138. Australia Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 175
Table 139. Australia Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 175
Table 140. Australia Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 176
Table 141. Australia Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 176
Table 142. Rest of Asia Pacific Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 177
Table 143. Rest of Asia Pacific Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 179
Table 144. Rest of Asia Pacific Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 179
Table 145. Rest of Asia Pacific Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 180
Table 146. Rest of Asia Pacific Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 180
Table 147. Rest of Asia Pacific Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 181
Table 148. Rest of Asia Pacific Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 181
Table 149. Rest of Asia Pacific Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 182
Table 150. Middle East & Africa Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 184
Table 151. Middle East & Africa Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 185
Table 152. Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 185
Table 153. Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 186
Table 154. Middle East & Africa Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 186
Table 155. Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 187
Table 156. Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 187
Table 157. Middle East & Africa Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 188
Table 158. Saudi Arabia Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 189
Table 159. Saudi Arabia Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 191
Table 160. Saudi Arabia Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 191
Table 161. Saudi Arabia Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 192
Table 162. Saudi Arabia Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 192
Table 163. Saudi Arabia Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 192
Table 164. Saudi Arabia Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 193
Table 165. Saudi Arabia Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 193
Table 166. Saudi Arabia Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 194
Table 167. South Africa Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 196
Table 168. South Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 196
Table 169. South Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 197
Table 170. South Africa Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 197
Table 171. South Africa Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 197
Table 172. South Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 198
Table 173. South Africa Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 198
Table 174. UAE Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 199
Table 175. UAE Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 201
Table 176. UAE Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 201
Table 177. UAE Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 202
Table 178. UAE Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 202
Table 179. UAE Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 202
Table 180. UAE Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 203
Table 181. UAE Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 203
Table 182. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 204
Table 183. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 206
Table 184. Rest of Middle East & Africa Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 206
Table 185. Rest of Middle East & Africa Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 207
Table 186. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 207
Table 187. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 208
Table 188. Rest of Middle East & Africa Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 208
Table 189. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 209
Table 190. South & Central America Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 211
Table 191. South & Central America Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 212
Table 192. South & Central America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 212
Table 193. South & Central America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 213
Table 194. South & Central America Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 213
Table 195. South & Central America Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 214
Table 196. South & Central America Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 214
Table 197. South & Central America Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 215
Table 198. Brazil Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 216
Table 199. Brazil Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 218
Table 200. Brazil Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 218
Table 201. Brazil Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 219
Table 202. Brazil Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 219
Table 203. Brazil Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 219
Table 204. Brazil Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 220
Table 205. Brazil Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 220
Table 206. Argentina Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 221
Table 207. Argentina Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 223
Table 208. Argentina Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 223
Table 209. Argentina Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 224
Table 210. Argentina Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 224
Table 211. Argentina Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 224
Table 212. Argentina Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 225
Table 213. Argentina Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 225
Table 214. Rest of South & Central America Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million) 226
Table 215. Rest of South & Central America Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million) 227
Table 216. Rest of South & Central America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million) 227
Table 217. Rest of South & Central America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million) 228
Table 218. Rest of South & Central America Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million) 228
Table 219. Rest of South & Central America Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million) 229
Table 220. Rest of South & Central America Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million) 229
Table 221. Rest of South & Central America Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million) 230
Table 222. Organic Developments Done By Companies. 232
Table 223. Inorganic Developments Done By Companies. 234
Table 224. Glossary of Terms, Infectious Disease Diagnostics Market 278

LIST OF FIGURES

Figure 1. Infectious Disease Diagnostics Market Segmentation, By Geography. 41
Figure 2. Global – PEST Analysis. 47
Figure 3. Infectious Disease Diagnostics Market – Key Industry Dynamics. 48
Figure 4. Impact Analysis of Drivers and Restraints. 53
Figure 5. Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 – 2030. 54
Figure 6. Infectious Disease Diagnostics Market Revenue, Geography (US$ Mn), 2022 – 2030. 55
Figure 7. Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%) 56
Figure 8. Kits & Reagents: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 57
Figure 9. Instruments: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 58
Figure 10. Software & Services: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 59
Figure 11. Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%) 60
Figure 12. Biosensor-based: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 61
Figure 13. Immunodiagnostics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 62
Figure 14. Molecular-Based Diagnostic Techniques: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 64
Figure 15. Clinical Biology: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 66
Figure 16. Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 67
Figure 17. Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%) 68
Figure 18. Point-of-Care Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 69
Figure 19. Laboratory Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 70
Figure 20. Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%) 71
Figure 21. Human Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 72
Figure 22. Veterinary Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 74
Figure 23. Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%) 75
Figure 24. Diagnostic Laboratories: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 76
Figure 25. Hospitals and Clinics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 77
Figure 26. Research Institutes: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 78
Figure 27. Homecare Settings: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 80
Figure 28. Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million) 81
Figure 29. North America: Infectious Disease Diagnostics Market, by Key Country – Revenue (2022) (US$ Million) 82
Figure 30. North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 83
Figure 31. North America Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 87
Figure 32. US Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 88
Figure 33. Canada Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 94
Figure 34. Mexico Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 100
Figure 35. Europe Infectious Disease Diagnostics Market, by Key Country – Revenue, 2022 (US$ Million) 105
Figure 36. Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 106
Figure 37. Europe Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 110
Figure 38. UK Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 111
Figure 39. Germany Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 117
Figure 40. France Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 123
Figure 41. Italy Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 129
Figure 42. Spain Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 134
Figure 43. Rest of Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 139
Figure 44. Asia Pacific Infectious Disease Diagnostics Market, by Key Country – Revenue, 2022 (US$ Million) 145
Figure 45. Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 146
Figure 46. Asia Pacific Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 151
Figure 47. China Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 151
Figure 48. Japan Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 157
Figure 49. India Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 162
Figure 50. South Korea Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 167
Figure 51. Australia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 172
Figure 52. Rest of Asia Pacific Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 177
Figure 53. Middle East & Africa Infectious Disease Diagnostics Market, by Key Country – Revenue, 2022 (US$ Million) 183
Figure 54. Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 184
Figure 55. Middle East & Africa Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 188
Figure 56. Saudi Arabia Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 189
Figure 57. South Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 194
Figure 58. UAE Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 199
Figure 59. Rest of Middle East & Africa Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 204
Figure 60. South & Central America Infectious Disease Diagnostics Market, by Key Country – Revenue, 2022 (US$ Million) 210
Figure 61. South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 211
Figure 62. South & Central America Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%) 215
Figure 63. Brazil Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 216
Figure 64. Argentina Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 221
Figure 65. Rest of South & Central America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) 226
Figure 66. Growth Strategies Done by the Companies in the Market, (%) 231

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the infectious disease diagnostics market.
● Highlights key business priorities in order to assist companies to realign their business strategies.
● The key findings and recommendations highlight crucial progressive industry trends in the global infectious disease diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets. 
● Scrutinize in-depth global infectious disease diagnostics market trends and outlook coupled with the factors driving the market, as well as those hindering it.
● Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

The List of Companies – Infectious Disease Diagnostics Market 
● Abbott Laboratories
● Bruker Corp
● Cardinal Health
● F. Hoffmann-La Roche Ltd
● Trinity Biotech Plc
● Danaher Corp
● Bio-Rad Laboratories Inc
● AccuBioTech Co Ltd
● ACON Laboratories
● DiaSorin SpA

Pricing

$4,550.00$8,550.00

Have a Query?

Have a Question?

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

GET FREE SAMPLE PDF

× Enquire Now